- 货号:MIRCP00016CAS:包装:250 REACTIONS分子式:纯度规格:Rat 4.5S-V1分子量:
- 货号:767719CAS:包装:500 μL分子式:纯度规格:10 mg/mL (in 1% citric acid)分子量:
- 货号:200274CAS:69861-89-8包装:25 MG, 100 MG分子式:纯度规格:Highly sensitive substrate for trypsin-like enzymes and granule-associated serine esterase.分子量:
- 货号:616387CAS:402-71-1包装:250 MG分子式:C17H18ClNO3S纯度规格:Irreversible inhibitor of chymotrypsin.分子量:351.85
- 货号:PH014193CAS:包装:100 MG分子式:C9H17N3纯度规格:AldrichCPR分子量:167.25
- 货号:PH017133CAS:1339469-00-9包装:250 MG分子式:C16H23O1N3纯度规格:AldrichCPR分子量:
- 货号:728357CAS:1211565-08-0包装:100 MG, 500 MG分子式:C22H26F3N3O2纯度规格:95%分子量:421.46
- 货号:PH014391CAS:包装:100 MG分子式:C10H13NO2纯度规格:AldrichCPR分子量:179.22
- 货号:PH000899CAS:1933734-05-4包装:25 MG分子式:C11H21N纯度规格:AldrichCPR分子量:
- 货号:PH014900CAS:包装:100 MG分子式:C16H23NO2纯度规格:AldrichCPR分子量:261.36
- 货号:689017CAS:782495-18-5包装:500 MG分子式:C6H11F3N2O2S纯度规格:≥98.5% (T)分子量:232.22
- 货号:1639003CAS:80-74-0包装:200 MG分子式:C13H15N3O4S纯度规格:United States Pharmacopeia (USP) Reference Standard分子量:309.34
- 货号:PH015824CAS:包装:250 MG分子式:C14H18Cl2N4OS纯度规格:AldrichCPR分子量:361.29
- 货号:PH017603CAS:1284629-22-6包装:500 MG分子式:C13H21O2N3纯度规格:AldrichCPR分子量:
- 货号:PH014729CAS:包装:100 MG分子式:C13H21N3O纯度规格:AldrichCPR分子量:235.33
- 货号:PH001271CAS:2095264-11-0包装:5 MG分子式:C20H17N纯度规格:AldrichCPR分子量:
| 共15223页,第12169页 |


![<i>N</i>-[(1-Isopropyl-1<i>H</i>-pyrazol-4-yl)methyl]ethanamine](/data/daily/2020/12/26/105753_609331_ex_464754.png)
![N-[(1-Methyl-1H-indol-3-yl)methyl]-2-(4-morpholinyl)ethanamine](/data/daily/2020/12/26/105938_392469_ex_464755.png)
![<i>N</i>-[(1<i>R</i>,2<i>R</i>)-2-(1-Piperidinyl)cyclohexyl]-<i>N</i>′-[4-(trifluoromethyl)phenyl]squaramide](/data/daily/2020/12/26/105807_971930_ex_464756.png)
![<i>N</i>-[(1<i>R</i>)-2-Hydroxy-1-phenylethyl]acetamide](/data/daily/2020/12/26/110048_097154_ex_464757.png)
![N-[(1S,5S)-5-Isopropenyl-2-methylcyclohexyl]-N-methylamine](/data/daily/2020/12/26/105357_144444_ex_464758.png)
![<i>N</i>-[(1<i>S</i>)-1-Phenylethyl]-1,4-dioxaspiro[4.5]decan-8-amine](/data/daily/2020/12/26/105927_793095_ex_464759.png)
![<i>N</i>-[(2<i>S</i>)-2-Pyrrolidinylmethyl]-trifluoromethanesulfonamide](/data/daily/2020/12/26/110020_139237_ex_464760.png)
![<i>N</i>-[(5-Methyl-2-pyrazinyl)methyl]-4,5,6,7-tetrahydrothieno[2,3-<i>c</i>]pyridine-3-carboxamide dihydrochloride](/data/daily/2020/12/26/105820_080781_ex_464762.png)
![N-[(6-Methoxy-3-pyridinyl)methyl]-2-(4-morpholinyl)ethanamine](/data/daily/2020/12/26/105411_966250_ex_464763.png)
![<i>N</i>-[(6-Methyl-2-pyridinyl)methyl]-2-(4-morpholinyl)ethanamine](/data/daily/2020/12/26/105404_025410_ex_464764.png)
![N-[(E)-[1,1′-Biphenyl]-4-ylmethylidene]-4-methylaniline](/data/daily/2020/12/26/105844_717196_ex_464765.png)















